RebrAIn
PrivateLast Round
Seed
Mar 18, 2024
Total Funding Raised
$4.03M
Momentum Score
25 /100
Company Overview
RebrAIn is a medical technology company that provides a precise targeting technology for helping with surgical treatments of neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Devices, Medical Imaging, Vertical SaaS, Precision Medicine
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RebrAIn Comps
Public and private peers based on sector, stage, and business model.
RebrAIn Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 18, 2024 |
RebrAIn Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Nouvelle-Aquitaine Co-investissement | Seed |
| Karista | Seed |
RebrAIn Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about RebrAIn's valuation, stock price, and market status.